Research Article

SAFETY OF VACCINE A DETERMINANT OF UTILIZATION OF COVID-19 VACCINES AMONG ACADEMIC STAFF OF COLLEGES OF EDUCATION IN NORTHERN STATES, NIGERIA

Abdullahi Y. Giade1*, UMAR MUSA2, Yahaya Harande3, Mariam A. Suleiman4
1 Department of Physical and Health Education, Aminu Saleh College of Education Azare, Bauchi State, Nigeria
2 New City Hospital and diagnostics Services Limited Zaria
3 Department of Human Kinetics and Health Education, Ahmadu Bello University, Zaria, Nigeria
4 Department of Physical and Health Education, Shehu Shagari College of Education, Sokoto
* Corresponding author: abdallahyunus73@gmail.com
Published: Aug, 2024
DOI: 10.67203/gjhrr.2024.hpjhefwv
Pages: 16-21
Views: 28
Downloads: 10

Abstract

The purpose of this study was to assess the safety of vaccines as a determinant of the utilization of COVID-19 vaccines among colleges of education academic staff in Northern States, Nigeria. To achieve the purpose of the study, one research question and hypothesis were formulated and tested for the study. The research design for this study was ex post facto research design. The target population for this study comprised 4,947 academic staff of the twelve Colleges of Education in the Northern States of Nigeria. Therefore, the sample for this study consists of 650 academic staff which were selected among colleges of education academic staff in Northern States, Nigeria by using multi stage sampling techniques. The instrument used for data collection was a researcher-developed close-ended questionnaire which was validated by five experts in the Department of Human Kinetics and Health Education, Public Health and Nursing Science at Ahmadu Bello University Zaria with a reliability coefficient of 0.80. Descriptive statistics of frequencies and percentages were used to describe the demographic information of the respondents; means and standard deviations to answer the research question, and inferential statistics of one-sample t-test was used to test the null hypotheses at 0.05 level of significance. The study findings revealed that the safety of the vaccine is a significant determinant of COVID-19 vaccine utilisation among academic staff of Colleges of Education in Northern Nigeria (t=115.134, P=0.000). Based on the findings of the study it was concluded that; the safety of the vaccine determines the utilization of the COVID-19 vaccine among the academic staff of the College of Education in Northern States, Nigeria. It was therefore recommended that FGN and NGOs should sensitize the general public on the safety of vaccines through symposiums, lectures, drama, seminars and magazines this will help in correcting misconceptions and improve the rate of utilization of the vaccines among colleges of education academic staff in the northern states, Nigeria. 

Keywords

Determinant Safety Utilization Vaccination COVID-19 Academic Staff

References

  1. Afolabi, M. O., Wariri, O., Saidu, Y., Otu, A., Omoleke, S. A., Ebenso, B., ... & Yaya, S. (2021). Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis. BMJ Global Health, 6(12), e007518.
  2. Akorede, S. N. (2021). Covid-19 lockdown and domestic violence against partners in Nigeria. KIU Interdisciplinary Journal of Humanities and Social Sciences, 2(2), 38-47
  3. Akorede, S. N., Ajayi, A. E., Atanda, T., & Uwadia, G. U. (2021). Influence of COVID-19 on the Psychological Wellbeing of Tertiary Institution Students in Nigeria. Tanzania Journal of Science, 47(1), 70-79
  4. Akorede, S. N., Isiya, G., & Usman, U. (2022). Acceptance of COVID-19 Vaccine among Staff of Federal College of Education, Katsina. ABSU Journal of Educational Studies, 9(3), 1-5.
  5. Alhulaibi, B. A., Alharbi, K. G., Alabdoodi, T. A., Alkanhal, H. M., Alobaid, M. M., Aldraimly, M. A., ... &Aldraimly, M. (2021). Factors and determinants for uptake of COVID-19 vaccine in a medical university in Riyadh, Saudi Arabia. Cureus, 13(9).
  6. Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450-452.
  7. Bajos, N., Spire, A., Silberzan, L., Sireyjol, A., Jusot, F., Meyer, L., ... &EpiCov Study Group. (2022). When lack of trust in the government and scientists reinforces social inequalities in vaccination against COVID-19. Frontiers in public health, 10, 908152.
  8. Clemente-Suárez, V. J., Navarro-Jiménez, E., Moreno-Luna, L., Saavedra-Serrano, M. C., Jimenez, M., Simón, J. A., & Tornero-Aguilera, J. F. (2021). The impact of the COVID-19 pandemic on social, health, and economy. Sustainability, 13(11), 6314.
  9. Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta bio medica: Atenei Parmensis, 91(1), 157.
  10. El-Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al-Sawalha, N. A., & Alali, F. Q. (2021). Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. Plos one, 16(4), e0250555.
  11. Idris, S. Y., Akorede, A. A., & Isiaq, A. T. (2022). Assessment of knowledge and practice of COVID-19 prevention strategies among Secondary School Students in Samaru, Zaria. Global Journal of Health Related Researches, 4(1), 16-23.
  12. Kaye, A. D., Okeagu, C. N., Pham, A. D., Silva, R. A., Hurley, J. J., Arron, B. L., ... & Cornett, E. M. (2021). Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Practice & Research Clinical Anaesthesiology, 35(3), 293-306.
  13. Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S., & Tang, J. W. (2020). Herd immunity–estimating the level required to halt the COVID-19 epidemics in affected countries. Journal of Infection, 80(6), e32-e33.
  14. Laires, P. A., & Nunes, C. (2020). Population-based estimates for high risk of severe COVID-19 disease due to age and underlying health conditions. Acta Medica Portuguesa, 33(11), 720-725.
  15. Lazarevic, I., Pravica, V., Miljanovic, D., &Cupic, M. (2021). Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses, 13(7), 1192.
  16. National Commission for Colleges of Education, Abuja (2017)
  17. Ohunuyiwa, O. O., Mbachu, C. O., Nwiru, N. C., &Uchegbu, O. I. (2022). Factors influencing COVID-19 vaccine hesitancy in Nigeria: A systematic review. International Journal of Infectious Diseases, 122, 212-220.
  18. Owolabi, M. O., Balogun, J. A., Adekunmbi, O. A., Nwizu, N. C., Uchegbu, O. I., &Mereunkwu, A. O. (2021). Covid-19 vaccine hesitancy in Nigeria: A qualitative exploration of reasons for hesitancy and acceptance. BMJ Global Health, 6(12), e007518. https://bmjopen.bmj.com/content/13/7/e068668)(https://bmjopen.bmj.com/content/13/7/e068668)
  19. Research Advisors (2006). Sample Size Table. http://research-advisors.com
  20. Tijani, B., Filmi, T., Oluyide, O., Odis, A., Enike, E., Adewemimo, A., ... &Akinreni, T. (2023). COVID-19 Vaccine Uptake and its Determinants: Findings From A Web-Based Survey in Nigeria. European Journal of Medical and Health Sciences, 5(4), 48-52.
  21. UNU-MERIT (2021). COVID-19 vaccine uptake in Sub-Saharan Africa. Retrieved at https://www.merit.unu.edu/covid-19-vaccine-africa/
  22. Wolfburg, P., Markhof, Y., Kanyanda, S., & Zezza, A. (2023). Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa. Communications medicine, 3(1), 121.
  23. World Health Organization (2015). Global vaccine hesitancy landscape and country context. Retrieved at https://www.who.int/news/item/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes - (Accessed May 21, 2022)
  24. World Health Organization (2020). WHO Director-General declares global health emergency over novel coronavirus (2019-nCoV).
  25. World Health Organization (WHO) (2020). Transmission of SARS-CoV-2: implications for infection prevention precautions. Retrieved from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions July 9, 2020; Accessed: July 13, 2020.
  26. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727-733.
How to Cite

Giade, A. Y., MUSA, U., Harande, Y., & Suleiman, M. A. . (2024). SAFETY OF VACCINE A DETERMINANT OF UTILIZATION OF COVID-19 VACCINES AMONG ACADEMIC STAFF OF COLLEGES OF EDUCATION IN NORTHERN STATES, NIGERIA. Global Journal of Health Related Researches, 6(2), 16-21. https://doi.org/10.67203/gjhrr.2024.hpjhefwv

A. Y. Giade, U. MUSA, Y. Harande, and M. A. . Suleiman, "SAFETY OF VACCINE A DETERMINANT OF UTILIZATION OF COVID-19 VACCINES AMONG ACADEMIC STAFF OF COLLEGES OF EDUCATION IN NORTHERN STATES, NIGERIA," Global Journal of Health Related Researches, vol. 6, no. 2, pp. 16-21, August 2024. doi: 10.67203/gjhrr.2024.hpjhefwv

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles